Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19

Summary

The study aims to evaluate the efficacy and safety of hydroxychloroquine in the treatment of COVID-19 pneumonia.

Timeline

Start

2020-02-06

Primary completion

2020-02-25

Completion

2020-02-25

Outcome

Missed primary endpoint

paper 13 (86.7%) cases in the HCQ group and 14 (93.3%) cases in the control group (P>0.05). PMID 32391667 ↗

Publications

• Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03. Chinese.

Drugs

Indications